Close

Raw Scripts for Gilead's (GILD) Harvoni Outpace Sovaldi Launch in Week Two, FBR Capital Notes

October 31, 2014 9:12 AM EDT Send to a Friend
FBR Capital analyst Andrew Berens noted Gilead Sciences (NASDAQ: GILD) Symphony Health Solutions weekly prescription data showed 1,409 total prescriptions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login